Form D · Biotechnology
LifeSprout, Inc.
Baltimore, MD · CIK 0001733815
Offering snapshot reported Jun 29, 2021 · SEC filing
- Reported sold
- $21.2M Offering amount: $26.2M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2021 | Amendment | $21,195,249 | No comparison | Not reported | SEC filing |
| Apr 21, 2020 | Initial | $2,999,993 | No comparison | 10 | SEC filing |
| Mar 8, 2018 | Initial | $2,700,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-365433
Source: Form D, filed Jun 29, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Xiaoming Fang | Director |
| Ming Fang | Director |
| Eric Goorno | Executive |
| Adam Gridley | Director, Promoter |
| Hai Quan Mao | Executive, Promoter |
| Heather Murren | Director |
| Amrit Nagpal | Director |
| Sashank Reddy | Director, Executive, Promoter |
| Gregory Sieczkiewicz | Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
101 W. Dickman St., Suite 900
Baltimore, MD, 21230
Baltimore, MD, 21230